References to Primary Literature
- Snyder, DW Fleisch, JH Ann. Rev. Pharmacol. Toxicol. 1989 29 123.
- Shaw, A Ann. Rep. Med. Chem. 1990 25 61.
- Masamune, H Melvtn, LS Jr Ibid 1989 24 61.
- Mallett, BE 196th ACS National Meeting, Los Angeles 1988 MEDI 127.
- Kreft, AF 2nd International Conference on Leukotrienes and prostanoids in Health and Disease Jerusalem 1988 Abst. #p10.
- Carter, GW 2nd International Conference on Leukotrienes and prostanoids in Health and Disease 1989 Brooks, DW, abst. #S4; 197th ACS Annual Meeting, Abstr. #MEDI 69.
- Joos, GF J. Allergy Clin. Immunol. 1989 83 187 #63; Creticos PS et al.: Ibid (1989) 83: 187 #62.
- Higgs, GA Flower, RJ Vane, JR Biochem. Pharmacol 1979 28 195.
- Otterness, IG 3rd Interscience World Conf. on Inflammation, Monte-Carlo 1989 371 Abstr.
References to Patent literature
- Eli Lilly & Co US 4992576.
- ICI PLC EP 0409414 A.
- ICI PLC EP 0409412 A, EP 0409413 A.
- ICI PLC EP 0410661 A.
- ICI PLC EP 0375404 A; EP 0385662 A; EP 0375452 A.
- Bayer AG EP 0409027 A.
- Merck Frosst Canada Inc US 4983628.
- Bayer AG EP 0410241 A, EP 0410244 A.
- Bayer AG EP 0414019 A.
- Bayer AG EP 0387610 A.
- Chemisch Pharmazeutiche EP 0406614 A.
- Abbott Laboratories EP 0416609 A.
- Fujisawa Pharm Co Ltd EP 0408760 A.
- Giba Geigy AG EP 0412939 A.
- Merrell Dow Pharm Inc EP 0409163 A.
- Teijin Ltd EP 0418038 A.
- AmithKline Beecham Corp EP 0403249 A; EP 0403252 A; EP 0403250 A.
- Schering Corp US 4988716.
- Greenwich Pharm Inc EP 0404136 A.
- Merck & Co Inc US 4978679.
- Glaxo Group Ltd US 4985427.
- Pfizer Inc EP 0409484 A.
- Rhone-Poulenc EP 0410834 A.
- American Home Products US 4988726.
- Warner-Lambert Co EP 0401857 A.